Empresa Neurokine Pharmaceuticals Inc Other OTC
Acciones
CAC611561100
Biotecnología e investigación médica
Precio de cierre
Otros sitios de cotización
|
||
- USD | - |
01/05 | BetterLife Pharma avanza en los estudios IND para BETR-001 | MT |
01/05 | BetterLife Pharma Inc. Avanza BETR-001 IND-Enabling Estudios | CI |
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Ahmad Doroudian
CEO | Chief Executive Officer | 63 | 17/09/07 |
Moira Ong
DFI | Director of Finance/CFO | 49 | 26/12/10 |
Chief Operating Officer | 67 | - | |
Wolfgang Renz
BRD | Director/Board Member | 54 | 05/02/15 |
David Melles
IRC | Investor Relations Contact | - | 29/09/21 |
Anthony Calandra
LAW | General Counsel | - | - |
Corporate Officer/Principal | - | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Ahmad Doroudian
CEO | Chief Executive Officer | 63 | 17/09/07 |
Robert Metcalfe
BRD | Director/Board Member | 84 | 21/01/20 |
Wolfgang Renz
BRD | Director/Board Member | 54 | 05/02/15 |
Ralph Pullen
BRD | Director/Board Member | 79 | 05/05/20 |
Steven Sangha
BRD | Director/Board Member | - | - |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 113 825 305 | 88 051 525 ( 77,36 %) | 0 | 77,36 % |
Información de la empresa
BetterLife Pharma, Inc.
1275 West 6th Avenue Suite 300
V6H 1A6, Vancouver
+604 221 0595
http://www.abetterlifepharma.comSector
Varia. 1 de ene. | Capi. | |
---|---|---|
+3,91 % | 109 mil M | |
+10,87 % | 105 mil M | |
+1,28 % | 22,25 mil M | |
-13,14 % | 22,09 mil M | |
-7,05 % | 18,68 mil M | |
-38,36 % | 17,58 mil M | |
-10,66 % | 16,85 mil M | |
+3,75 % | 13,76 mil M | |
+36,70 % | 12,46 mil M |
- Bolsa de valores
- Acciones
- Acción BETRF
- Acción
- Empresa Neurokine Pharmaceuticals Inc